Cullinan Associates’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.12M Sell
4,154
-2,375
-36% -$707K 0.09% 117
2025
Q4
$2.16M Sell
6,529
-2,448
-27% -$830K 0.15% 99
2025
Q3
$3.1M Sell
8,977
-1,421
-14% -$430K 0.2% 84
2025
Q2
$3.24M Sell
10,398
-3,990
-28% -$1.52M 0.21% 83
2025
Q1
$7.54M Sell
14,388
-4,110
-22% -$2.1M 0.53% 47
2024
Q4
$9.36M Buy
18,498
+950
+5% +$540K 0.6% 42
2024
Q3
$10M Sell
17,548
-3,404
-16% -$1.93M 0.57% 42
2024
Q2
$10.7M Buy
20,952
+4,298
+26% +$2.11M 0.6% 42
2024
Q1
$8.24M Sell
16,654
-3,332
-17% -$1.69M 0.46% 55
2023
Q4
$10.5M Sell
19,986
-4,569
-19% -$2.44M 0.59% 37
2023
Q3
$12.4M Sell
24,555
-1,465
-6% -$721K 0.72% 33
2023
Q2
$12.5M Sell
26,020
-665
-2% -$325K 0.69% 36
2023
Q1
$12.6M Buy
26,685
+317
+1% +$153K 0.74% 37
2022
Q4
$14M Buy
26,368
+700
+3% +$371K 0.77% 28
2022
Q3
$13M Sell
25,668
-1,400
-5% -$736K 0.82% 32
2022
Q2
$13.9M Buy
27,068
+555
+2% +$279K 0.85% 29
2022
Q1
$13.5M Sell
26,513
-1,932
-7% -$932K 0.71% 40
2021
Q4
$14.3M Sell
28,445
-2,777
-9% -$1.26M 0.73% 41
2021
Q3
$12.2M Buy
31,222
+975
+3% +$404K 0.67% 45
2021
Q2
$12.1M Sell
30,247
-4,660
-13% -$1.86M 0.68% 43
2021
Q1
$13M Buy
34,907
+260
+0.8% +$90.1K 0.75% 30
2020
Q4
$12.2M Buy
34,647
+1,930
+6% +$647K 0.73% 28
2020
Q3
$10.2M Sell
32,717
-9,620
-23% -$2.95M 0.66% 33
2020
Q2
$12.5M Sell
42,337
-1,660
-4% -$476K 0.88% 24
2020
Q1
$11M Sell
43,997
-15,505
-26% -$4.27M 0.9% 17
2019
Q4
$17.5M Sell
59,502
-1,080
-2% -$283K 1.17% 17
2019
Q3
$13.2M Buy
60,582
+1,067
+2% +$257K 0.94% 21
2019
Q2
$14.5M Buy
59,515
+14,885
+33% +$3.58M 1.05% 17
2019
Q1
$11M Buy
44,630
+12,095
+37% +$3.08M 0.83% 26
2018
Q4
$8.11M Sell
32,535
-230
-0.7% -$60.8K 0.67% 37
2018
Q3
$8.72M Buy
32,765
+3,935
+14% +$1.02M 0.63% 41
2018
Q2
$7.07M Sell
28,830
-7,785
-21% -$1.87M 0.54% 49
2018
Q1
$7.84M Sell
36,615
-525
-1% -$120K 0.59% 40
2017
Q4
$8.19M Sell
37,140
-870
-2% -$184K 0.6% 40
2017
Q3
$7.44M Buy
38,010
+10,885
+40% +$2.1M 0.57% 47
2017
Q2
$5.03M Buy
27,125
+945
+4% +$166K 0.39% 69
2017
Q1
$4.29M Sell
26,180
-7,457
-22% -$1.22M 0.35% 76
2016
Q4
$5.38M Buy
33,637
+1,250
+4% +$187K 0.46% 64
2016
Q3
$4.53M Buy
32,387
+2,420
+8% +$339K 0.39% 75
2016
Q2
$4.23M Buy
29,967
+2,517
+9% +$336K 0.34% 78
2016
Q1
$3.54M Buy
27,450
+1,500
+6% +$177K 0.3% 88
2015
Q4
$3.05M Buy
25,950
+13,300
+105% +$1.55M 0.27% 89
2015
Q3
$1.47M Buy
+12,650
New +$1.51M 0.13% 122
2015
Q2
Sell
-2,210
Closed -$261K 214
2015
Q1
$261K Buy
+2,210
New +$245K 0.02% 205
2014
Q3
Sell
-28,100
Closed -$1.84M 97
2014
Q2
$1.84M Buy
+28,100
New +$2.21M 0.3% 47
2013
Q3
Sell
-29,800
Closed -$1.95M 91
2013
Q2
$1.95M Buy
+29,800
New +$1.85M 0.26% 51

Other funds holding UNH

Cullinan Associates's UNH Position: Q1 2026 in Review

Cullinan Associates reduced its UnitedHealth (UNH) stake by 36% in Q1 2026, selling an estimated $707K and leaving 4,154 shares worth $1.12M. The position accounts for 0.09% of the portfolio, ranked #117.

Cullinan Associates first reported a position in UNH in Q2 2013 and has held it in 46 quarters since. The position peaked at $17.5M in Q4 2019. 3,019 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • Cullinan Associates held 4,154 shares of UnitedHealth worth $1.12M as of Q1 2026.
  • Cullinan Associates sold 2,375 UnitedHealth shares in Q1 2026, an estimated $707K.
  • UnitedHealth made up 0.09% of Cullinan Associates's portfolio in Q1 2026, its #117 holding.
  • Cullinan Associates first reported a position in UnitedHealth in Q2 2013 and has held it in 46 quarters since.
  • Cullinan Associates's UnitedHealth position peaked at $17.5M in Q4 2019.
  • 3,019 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on Cullinan Associates's 13F filing for Q1 2026, filed 1 May 2026.